AWK — American Water Works Company, Inc.

The tape says indifferent, and the sell side agrees. As of 2026-09-13 the stock was -2.14% over the prior week (classic sell-the-news after the 2026-09-09 NJ rate settlement), +2.05% over one month, +9.01% over three months, but still -1.43% over six months - a bond-proxy utility grinding sideways, not a momentum name. Consensus is a Hold: the FMP data shows 14 buy / 14 hold / 2 sell with an average target of $140.50 and a recent-average target of $145.25 (range $130-$162), while the live brief reports a more cautious ~3 buy / 9-10 hold / 1 sell split with a ~$140 consensus target. Either way the average target sits only ~2-6% above the 2026-09-13 price. Bulls point to the NJ rate case, $216M of annualized authorized revenue secured YTD, the HSR clearance on the Essential Utilities merger (2026-08-17) and UBS's $162 target; bears point to negative free cash flow in all 12 quarters, 5.20% coupon debt funding, and a stock that hasn't made progress in six months.

Revenue growth has clearly decelerated from its 2024 peak but has stabilized, not deteriorated. YoY revenue growth ran +13.4% (Q3'24), +16.4% (Q4'24), +12.9% (Q1'25), +11.1% (Q2'25), then stepped down to +9.7% (Q3'25), +5.8% (Q4'25), +5.7% (Q1'26) and +6.2% (Q2'26) - a step-down from low-double-digit to a steady ~6% run rate driven by acquisitions (Nexus Water, 47,000 connections, closed 2026-06-01; Neosho, $34.5M) plus rate relief. Margins are quietly expanding: Q2'26 operating margin was 40.0% ($542M on $1,355M) vs 38.3% in Q2'25, and net margin 23.2% vs 22.7%. EPS is choppier than revenue: Q2'26 EPS of $1.61 was +8.8% YoY, but Q1'26 EPS of $1.01 was -3.8% YoY on +5.7% revenue, and Q4'25 EPS of $1.22 was -0.8% YoY - the gap between revenue growth and EPS growth is financing cost, not operations. Full-year EPS: FY24 $5.39, FY25 $5.69 (+5.6%), FY26 guided to $6.02-$6.12 (+5.8% to +7.6%). Verdict: stable, mid-single-digit compounding with modest margin expansion - not accelerating, not rolling over. One data caveat: the Q4 2025 'gross profit' of -$171M is internally inconsistent with $1,271M of revenue and $405M of operating income and looks like a data/reclassification artifact, not a real margin collapse.

Fair, and cheap versus the company's own history. As of 2026-09-13, AWK's TTM P/E was 23.8x and its forward P/E ~22.6x ($137.69 / $6.082 FY26 consensus), versus a 5-year average P/E of 26.8x - roughly a 13% discount. Price/sales of 5.18x compares to a 5-year average of 6.44x, a ~20% discount. The headline PEG of 5.75 is misleading: it's built on trailing mid-single-digit EPS growth, which is simply what a regulated water utility earns, and PEG is a poor lens for rate-case-driven earnings. At 2.31x book and ~15.0x EV/EBITDA the stock sits in line with the regulated-water peer group rather than at a premium. The honest read: the multiple compression from ~27x to ~23x over three years reflects the rate shock, not earnings deterioration - earnings went up every year.

This is a multiple story, not an earnings story. At $137.69 you are paying 22.6x FY26 EPS of $6.082 for a business that will mechanically earn 6-7% more next year through rate cases and rate-base growth, plus a ~2.6% dividend. That math implies roughly a 9% total return if the multiple holds - fine, but not exciting. The asymmetry is in the multiple: a single turn of de-rating (to ~21x) wipes out an entire year of EPS growth (~$128), while a re-rate back toward the 5-year average of 26.8x would imply ~$163. Because revenue is tariff-driven rather than demand-driven, a macro fade hits the multiple, not the earnings - which means the earnings estimates you see are more reliable than the price they trade at.

As of 2026-09-13, the picture was neutral and range-bound, not oversold or overbought: RSI 50.36, price 0.34% below its 20-day SMA (~$138.16), 1.47% above its 50-day SMA (~$135.69) and 4.52% above its 200-day SMA (~$131.74). The 200-day slope is up, so the structural trend is positive, but the stock has spent six months going nowhere (-1.43%) inside a $120.57-$145.64 52-week range. Entry implication: no urgency here. A pullback into the 50-day around $135 or toward the 200-day in the low $130s would offer a materially better risk/reward than chasing a stock that just faded 2.14% in a week on good news; a break above the $145.64 high on volume would be the trend-confirmation signal instead.

• Interest rates and financing costs: AWK is directing roughly $3.7B of investment in 2026 and $19-20B through 2030, funded largely with debt (it priced $700M of senior notes at 5.20%). Every quarter of negative free cash flow pushes it back to the debt and equity markets, so higher-for-longer rates hit both affordability and the multiple - and the 0.58 beta means the stock trades off the 10-year, not the S&P 500.
• Regulatory outcomes and lag: earnings are set by state commissions, not by demand. AWK has secured $216M of annualized authorized revenue YTD through mid-2026, including the $68M New Jersey settlement (effective 2026-09-15, 9.5% authorized ROE, $6.06B rate base) - supportive, but any case decided below request directly compresses the growth rate.
• Rate affordability politics: water bills are a visible, local political issue; sustained inflation in chemicals, power and labor makes above-inflation rate increases harder to justify in front of commissions and can lengthen the lag between spending and recovery.
• Defensive sector rotation: with a 0.58 beta and a ~2.6% yield, AWK is a bond proxy - it attracts flows when growth and credit risk are feared and underperforms in pro-cyclical rotations, independent of its own fundamentals.
• Industry consolidation tailwind: U.S. water is highly fragmented and capital-starved, letting well-capitalized buyers absorb municipal and small private systems accretively; the pending all-stock merger with Essential Utilities (announced Oct 2025, HSR waiting period expired 2026-08-17, expected close by Q1 2027) would create a combined entity with 4.7M+ water/wastewater connections and 740,000 gas connections.

• Q3 2026 earnings, expected around 2026-10-27/28: watch capex execution, any update to the $6.02-$6.12 FY26 guidance, and merger integration commentary.
• Essential Utilities merger closing by end of Q1 2027 - remaining state approvals plus any divestiture conditions; the HSR clearance on 2026-08-17 removed the biggest antitrust hurdle.
• Pending rate cases and infrastructure surcharges (California and Missouri proceedings cited), plus the revenue impact from the New Jersey increase effective 2026-09-15.
• Fixed-income market access and the path of the 10-year Treasury - a sustained decline in rates would both cut financing costs and support a re-rate toward the 5-year average P/E of 26.8x.

• Financing structure: free cash flow was negative in every one of the last 12 quarters (-$1.03B TTM: -$258M in Q2'26, -$354M in Q1'26), debt/equity is 1.377, cash is only $191M against $3.27B of current liabilities (current ratio 0.52). That is normal for a rate-base-growth utility, but it means AWK is permanently dependent on capital markets - and the 4.2% reported ROIC sits uncomfortably close to or below a realistic cost of capital if capital deployment lags recovery.
• Regulatory risk: rate cases are the earnings engine. A single adverse order - a lower authorized ROE than requested, a disallowed cost, or a longer lag - moves multi-year EPS off plan in a way that a formula can't hedge.
• Merger-related dilution and integration risk: the all-stock deal with Essential Utilities adds a gas distribution business and closes near Q1 2027; the FY26 consensus EPS of $6.082 does not reflect the combined company, so 2027 estimates are structurally uncertain.
• Multiple/rate risk: at 22.6x forward with ~6% EPS growth, the stock is not cheap enough to absorb another leg of multiple compression if the 10-year backs up; a de-rate a single turn of P/E offsets a full year of earnings growth.

AWK is a genuinely good regulated business wearing a misleadingly bad scorecard: ~6% revenue growth, Q2'26 operating margin expanding to 40.0% from 38.3%, federal and state rate relief landing on schedule, a 2.6% dividend, and a 0.58 beta. The problem is price, not quality - at $137.69 on 2026-09-13 you pay 22.6x forward EPS for 6-7% growth and ~9% expected total return, with roughly 4% upside to my calculated fair value of about $143 and the average analyst target (~$140) essentially at the market price. I would own this as a defensive income holding and would be a buyer into the low $130s or on a break above $145.64, but at $137.69 the risk/reward is balanced rather than compelling. This is analysis, not personalized financial advice.

Calculated as a justified forward P/E: I applied 23.5x to the FY2026 EPS estimate of $6.082 (consensus, within management's reaffirmed $6.02-$6.12 range), giving ~$142.9, rounded to $143.00. The 23.5x is anchored between the current forward multiple of 22.6x and TTM 23.8x, and the 5-year average P/E of 26.8x - a discount to the company's own low-rate-era average to reflect 5.20% debt funding costs and permanently negative free cash flow, and a premium to the current multiple for a 2.6% dividend yield, 0.58 beta and visible 6-7% rate-base-driven EPS growth; the result sits ~4% above the 2026-09-13 price of $137.69 and is consistent with the ~$140-$145 analyst consensus (not copied from it). At $143 the implied forward P/E is still ~13% below the 5-year average of 26.8x and the implied P/S (~5.4x) remains below the 6.44x 5-year average, so the fair-value estimate is not a re-rating call - it is a discount-to-history call.